| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/30/2009 | WO2009074318A3 Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies |
| 07/30/2009 | WO2009071892A3 Method for the detection of dead and dying cells |
| 07/30/2009 | WO2009055200A3 Downhole spectroscopic hydrogen sulfide detection |
| 07/30/2009 | WO2009048530A3 Highly multiplexed particle-based assays |
| 07/30/2009 | WO2009037660A3 Analysing the binding of cell membrane bound molecules |
| 07/30/2009 | WO2009025793A8 Human t2r bitterness receptors and uses thereof |
| 07/30/2009 | WO2009001101A3 Sample plate |
| 07/30/2009 | WO2008157302A3 Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling |
| 07/30/2009 | WO2008151631A8 Use of short oligonucleotides for reagent redundancy experiments in rna functional analysis |
| 07/30/2009 | WO2008125733A8 Immunoassay for quantification of an unstable antigen selected from bnp and probnp |
| 07/30/2009 | WO2008119882A8 Screening methods based on human adam12 polypeptide and binding agents thereof |
| 07/30/2009 | WO2008118202A8 Ret-based analyte detection |
| 07/30/2009 | WO2008116032A8 Compositions and methods for inhibiting tumor cell growth |
| 07/30/2009 | WO2008107523A8 A fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins |
| 07/30/2009 | WO2008090263A8 Preli - a novel t-cell regulator |
| 07/30/2009 | WO2008087254A8 Method for detection of human immunodeficiency virus |
| 07/30/2009 | WO2008046964A8 Novel useful inhibitors |
| 07/30/2009 | WO2007112330A8 Compositions and methods for detection, prognosis and treatment of colon cancer |
| 07/30/2009 | WO2007104263A8 An enhancin of hepatitis b virus vaccine and its gene |
| 07/30/2009 | WO2007103788A8 Yeast reporter system based on fusion proteins of sup35p |
| 07/30/2009 | WO2007095634A8 Prion protein detection |
| 07/30/2009 | WO2007085706A8 Method for screening substances for treatment of neuropsychiatric diseases and materials therefor |
| 07/30/2009 | US20090193531 Methods and compositions for RNA Interference |
| 07/30/2009 | US20090192820 Assay system and method |
| 07/30/2009 | US20090192724 Transcutaneous analyte sensor |
| 07/30/2009 | US20090192723 Dosimeter for vibrations |
| 07/30/2009 | US20090192722 Systems and methods for processing sensor data |
| 07/30/2009 | US20090192721 Metabolic phenotyping |
| 07/30/2009 | US20090192719 Exploratory visualization of protein complexes by molecular weight |
| 07/30/2009 | US20090192294 Magi polynucleotides, polypeptides, and antibodies |
| 07/30/2009 | US20090192293 Antibodies to non-functional p2x7 receptor |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192193 Diagnostic agent and method for detection of cancer and a means for treatment of same |
| 07/30/2009 | US20090192189 Treatment of cancers expressing p95 erbb2 |
| 07/30/2009 | US20090192170 N-((S)-1-cyclopentyl-2-oxo-2-((3aS,6aR)-3-oxodihydro-2H-furo[3,2-b]pyrrol-4(5H,6H,6aH)-yl)ethyl)-4-(4-methylpiperazin-1-yl)benzamide; osteoporosis, Paget's disease, Chagas's, malaria, gingival diseases, hypercalcemia, metabolic bone disease, bone cancer and associated pain |
| 07/30/2009 | US20090192140 Iap bir domain binding compounds |
| 07/30/2009 | US20090192133 Treatment for achondroplasia |
| 07/30/2009 | US20090192119 Inhibition of the Renin-Angiotensin System for the Treatment of Renal, Vascular and Cartilage Pathology |
| 07/30/2009 | US20090192109 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Kremen and/or Wnt |
| 07/30/2009 | US20090192108 Gene overexpressed in cancer |
| 07/30/2009 | US20090192100 Novel use of spiegelmers |
| 07/30/2009 | US20090192091 Peptide inhibitors of protein kinase C |
| 07/30/2009 | US20090192090 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |
| 07/30/2009 | US20090192086 Identification of a novel bhd gene |
| 07/30/2009 | US20090192084 Compositions and method of treating hypoxia-associated diseases |
| 07/30/2009 | US20090192078 Methods for diagnosis of cardiovascular disease |
| 07/30/2009 | US20090192063 Final Drive and Powershift Transmission Lubricants |
| 07/30/2009 | US20090191650 Diagnosing alzheimer's disease via presence of variant brain membrane protein |
| 07/30/2009 | US20090191649 Biosensor and method of assaying object |
| 07/30/2009 | US20090191648 Method and device to detect the presence of analytes in a sample |
| 07/30/2009 | US20090191647 Antibody Pair Screening Methods |
| 07/30/2009 | US20090191646 Molybdenum complex & test kit to enhance accuracy of analysis of endogenous analytes in biological fluids |
| 07/30/2009 | US20090191645 Compounds and methods for modulating integrin activity |
| 07/30/2009 | US20090191644 Imprinted polymer for binding of organic molecules or metal ions |
| 07/30/2009 | US20090191642 Compositions, Systems, and Methods for Continuous Glucose Monitoring |
| 07/30/2009 | US20090191641 Immunodiagnostic test cards having indicating indicia |
| 07/30/2009 | US20090191640 Methods of Screening for Atherosclerosis |
| 07/30/2009 | US20090191639 Non-Invasive Rapid Diagnostic Test For M.Tuberculosis Infection |
| 07/30/2009 | US20090191637 Method and apparatus for determining anticoagulant therapy factors |
| 07/30/2009 | US20090191610 Microorganisms With Increased Efficiency for Methionine Synthesis |
| 07/30/2009 | US20090191584 Transcriptional repression of sodium-iodide symporter in thyroid carcinoma |
| 07/30/2009 | US20090191579 Analgesia with minimal tolerance and dependence by a mu opioid receptor agonist that also binds filamin a |
| 07/30/2009 | US20090191575 Tumor marker and method for determination of the occurrence of cancerous disease |
| 07/30/2009 | US20090191574 Methods, Products and Treatments for Diabetes |
| 07/30/2009 | US20090191573 Method and kit for determining antigen content in a sample using double immunohistochemical detection |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191571 Isolation and Detection of Pathogenic Prions |
| 07/30/2009 | US20090191570 Inhibition of Interaction of PSD93 and PSD95 with nNOS and NMDA Receptors |
| 07/30/2009 | US20090191569 Mammalian Cytokines; Related Reagents |
| 07/30/2009 | US20090191567 Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
| 07/30/2009 | US20090191559 Her2 diagnostic methods |
| 07/30/2009 | US20090191558 Detection, identification and differentiation of serratia species using the spacer region |
| 07/30/2009 | US20090191557 MN/CA IX/CA9 and renal cancer prognosis |
| 07/30/2009 | US20090191555 HCV NS3-NS4 Protease Resistance Mutants |
| 07/30/2009 | US20090191550 Diagnosis of whipple's disease |
| 07/30/2009 | US20090191544 localized portions of tissue sample are obtained and then testing using homogenization method can be carried out only on a specific area which has been found to have the tumor; reduces costs, artifacts and difficulties introduced by fixation and staining may be reduced |
| 07/30/2009 | US20090191543 Identification of rac1b as a marker and mediator of metalloproteinase-induced malignancy |
| 07/30/2009 | US20090191542 Multi-variant cell indication technique |
| 07/30/2009 | US20090191539 Primers for isothermal amplification of hepatitis C virus |
| 07/30/2009 | US20090191318 Machine and method for the treatment of liquid or semi-liquid food mixtures |
| 07/30/2009 | US20090191241 Method and compositions for immunization with the pseudomonas v antigen |
| 07/30/2009 | US20090191239 Recombinant infectious laryngotracheitis virus and uses thereof |
| 07/30/2009 | US20090191234 Vaccine |
| 07/30/2009 | US20090191231 Prevention and treatment of amyloidogenic disease |
| 07/30/2009 | US20090191228 Immunogenic compositions capable of activating T-cells |
| 07/30/2009 | US20090191222 Metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression |
| 07/30/2009 | US20090191220 Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists |
| 07/30/2009 | US20090191219 Methods for diagnosing and treating obesity by modulating the activity of auto-antibodies against the melanocortin-4 receptor |
| 07/30/2009 | US20090191209 Methods and compositions for targeting polyubiquitin |
| 07/30/2009 | US20090191207 Compositions and methods for the prophylaxis or treatment of viral diseases |
| 07/30/2009 | US20090191198 Methods for blocking the interaction between nkp80 and its ligands |
| 07/30/2009 | US20090191197 Cancerous disease modifying antibodies |
| 07/30/2009 | US20090191191 Methods for the Modulation of IL-13 |
| 07/30/2009 | US20090191190 Anti-ABeta Globulomer Antibodies, Antigen-Binding Moieties Thereof, Corresponding Hybridomas, Nucleic Acids, Vectors, Host Cells, Methods of Producing Said Antibodies, Compositions Comprising Said Antibodies, Uses Of Said Antibodies And Methods Of Using Said Antibodies |
| 07/30/2009 | US20090191189 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 07/30/2009 | US20090191182 Compositions, Kits, and Methods for the Modulation of Immune Responses Using Galectin-1 |
| 07/30/2009 | US20090191159 Multipotent/pluripotent cells and methods |
| 07/30/2009 | US20090191120 Cancerous disease modifying antibodies |